XXIst

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

RIDGEFIELD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 results from the RE-NOVATE(TM) trial demonstrated that oral dabigatran etexilate once daily, administered for an average of 33 days, was non-inferior to enoxaparin, also administered for an average of 33 days, in preventing venous thromboemb...

Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis

...olorectal cancer, and preclinical data evaluating the mechanism of NU172, a short-acting, direct thrombin inhibiting aptamer, will be presented at the xxist Congress of the International Society on Thrombosis and Haemostasis (ISTH) taking place in Geneva, Switzerland, July 6-12, 2007. The presentatio...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

...ignificant 44% reduction in venous thromboembolism (VTE) events (Deep Vein Thrombosis and / or Pulmonary Embolism). The findings were presented at the xxist ISTH Congress (International Society on Thrombosis and Haemostasis) in Geneva, Switzerland. Acutely ill medical patients are at high risk of VTE. Th...

International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis

...c International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study presented today at the xxist International Society on Thrombosis and Haemostasis (ISTH) congress in Geneva. VTE is a preventable disease which contributes significantly to morbi...

Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease

...gnificant correlation between serum levels of the Company's patented AtherOx(TM) bio-markers and cardiovascular disease. The data was presented at the xxist Congress of the International Society on Thrombosis and Hemostasis (ISTH) in Geneva, Switzerland. Data released this week shows the association of an...

New Information on the Potential of Plasmin Shared at ISTH Congress

... and development program for Plasmin (Human), TAL-05-00018, was presented by Talecris Biotherapeutics, Inc. (http://www.talecris.com) this week at the xxist International Society for Thrombosis and Haemostasis (ISTH) Congress in Geneva, Switzerland. The information included new data and updates on continui...

Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting

...tary forms of recombinant Factor IX to treat patients with Hemophilia B. The data were highlighted in an oral presentation and a poster session at the xxist Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Geneva, Switzerland. Dougald M. Monroe, Ph.D., Associate Professor, UN...